Article Excerpt: Delpor, a biotech company is working on a technology that would provide a longer-lasting delivery system for naltrexone. The company is developing a titanium implant that goes under the skin, where it slowly and steadily releases medication into the body for a year. Delpor’s aim is to give patients more options and make it easier for them to stay on treatment long enough to achieve long-term recovery from the disease as many people who start medication treatment for opioid use disorder don’t receive treatment long enough to recover.
Full Article: https://tinyurl.com/uopx8zl
Article Source: Patch